Public-Private Forum “From Molecules to treatments: Business models for new drug discovery”

Drug discovery in the modern era is a long and complex process that depends on multiple scientific disciplines and technologies, among which is the use of various high-resolution structural biology methods. It also relies on strong partnerships between various stakeholders, such as academia, the pharmaceutical industry, SMEs, regulators, patients, etc.

EATRIS, the European Research Infrastructure for Translational Medicine, and Biocat, the life sciences and health innovation cluster organization in Catalonia, join forces to propose this forum in the framework of iNext-Discovery, a project H2020 which facilitates access to research infrastructures in structural biology for all European researchers, with a threefold objective:

• Familiarize drug discovery scientists, including structural biologists, with the full drug development process and the partnership opportunities it can provide, both in academia and industry. 
• Stimulate wider adoption of methods of early drug discovery and structural biology in various scientific disciplines and research sectors. 
• Encourage collaboration between the different stakeholders in drug discovery.

This event is designed for:

• Biomedical researchers with an interest and/or first experience working with industry. 
• Scientific infrastructures, platforms and research centers (e.g. target providers, biobanks, compound libraries) involved in early drug development and want to understand the commercialization landscape and partnerships.
• Entrepreneurs and researchers who want to develop a business activity (eg start-up, spin-off, license, co-development).
• Corporations who want to learn about challenges and ideas in academia. 
• Research institutes linked to hospitals that provide or need scientific foundations for the discovery of new drugs.

La inscripció és gratuïta i està oberta des del 2 d'abril fins a l'1 de juny de 2024. La sala té una capacitat limitada, així que assegura't de registrar-te aviat – primer arribat, primer servit!

Els membres d'iNext-Discovery poden beneficiar-se d'una beca de viatge per cobrir les seves despeses de transport i allotjament.

Biocat: It acts as a catalyst to promote and transform the life sciences and health innovation ecosystem in Catalonia, known as the BioRegion of Catalonia. Established in 2006, it identifies key ecosystem challenges such as innovation, technology transfer, talent development and investment attraction. It develops initiatives and supports programs to maximize the economic and social impact of the sector.

EATRIS: It is the European infrastructure for translational medicine, offering access to expertise and facilities from more than 150 academic centers in Europe. It focuses on improving the preclinical and initial clinical development of drugs, vaccines and diagnostics, overcoming barriers to innovation in health. Collaborate with public funding agencies, charities and policy makers to improve the translational research and innovation ecosystem.

iNext-Discovery, the project whose objective is to facilitate access to research infrastructures in structural biology for all European researchers, including non-experts. It brings together several large research facilities and other groups in a unique consortium. Funded by the European Commission's Horizon-2020 program from February 2020 to July 2024, it is based on three pillars: transnational access, training and networking activities, and joint research. Academic and industrial researchers are encouraged to use these facilities for research in sectors such as health, biotechnology, biomaterials and food science.